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Abstract
Purpose We examined the association between negative
and positive affect and 12-month health status in patients
treated with percutaneous coronary intervention (PCI) with
drug-eluting stents.
Methods Consecutive PCI patients (n = 562) completed
the Global Mood Scale at baseline to assess affect and the
EuroQoL-5D (EQ-5D) at baseline and 12-month follow-up
to assess health status.
Results Negative affect [F(1, 522) = 17.14, P \ .001]
and positive affect [F(1, 522) = 5.11, P = .02] at baseline
were independent associates of overall health status at 12-
month follow-up, adjusting for demographic and clinical
factors. Moreover, there was a significant interaction for
negative by positive affect [F(1, 522) = 6.11, P = .01]. In
domain-specific analyses, high negative affect was asso-
ciated with problems in mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression with the risk being
two to fivefold. Low positive affect was only associated
with problems in self-care (OR: 8.14; 95% CI: 1.85–35.9;
P = .006) and usual activities (OR: 1.87; 95% CI: 1.17–
3.00; P = .009).
Conclusions Baseline negative and positive affect con-
tribute independently to patient-reported health status
12 months post PCI. Positive affect moderated the detri-
mental effects of negative affect on overall health status.
Enhancing positive affect might be an important target to
improve patient-centered outcomes in coronary artery
disease.
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Abbreviations
CABG Coronary artery bypass graft surgery
CAD Coronary artery disease
EQ-5D EuroQol-5 dimensions
EQ VAS EuroQol visual analogue scale
GMS Global Mood Scale
MI Myocardial infarction
MVD Multi-vessel disease
PCI Percutaneous coronary intervention
Introduction
Self-reported health status has gained recognition as an
important outcome measure in patients with coronary
artery disease (CAD) [1, 2], in part due to improved
treatment options [3], but also due to subgroups of patients
preferring health status and a reasonable quality of life
over prolonged survival [4]. In addition, studies have
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shown that health status is associated with mortality and
rehospitalization both in patients with CAD and chronic
heart failure [5–7]. Hence, one of the goals of treatment is
to enhance the patient’s health status and well being in
addition to prolonging survival [8].
However, there is a significant gap in our understanding
of the determinants of health status outcomes in patients
with CAD, which knowledge is paramount in order to
identify patients who may benefit from additional treatment
and support [2]. Furthermore, the primary focus has been
on the role of negative affect, such as depression and
anxiety [9, 10], neglecting the role of positive affect,
thereby failing to acknowledge that patients are not likely
to characterize themselves by negative emotions alone
[11].
Positive affect refers to feelings of joy, activity, and
happiness [12] and is not merely the opposite of negative
affect [13], since people can experience both types of affect
at the same time [14]. Studies on the healthy elderly
revealed that positive affect may influence perceived health
status independent of and even more strongly than negative
affect [15, 16].
The few studies that have examined the influence of
positive and negative affect on health status simultaneously
in CAD patients showed that positive affect moderated the
detrimental effects of depressed affect on outcome [17–19].
These preliminary results suggest that negative and posi-
tive affect may both contribute uniquely to health status
outcomes in CAD patients, but findings are limited and
inconclusive about their independent value.
Hence, the objective of the current study was to deter-
mine the relative association of negative and positive affect
assessed at baseline with 12-month overall health status
and specific health status domains in patients treated with
percutaneous coronary intervention (PCI) with drug-eluting
stenting.
Method
Study design and participants
Consecutive patients treated with PCI with the paclitaxel-
eluting stent in the period from 15 February 2005 to 14
February 2006 in the Erasmus Medical Center Rotterdam,
The Netherlands, comprised the sample for the current
study. All surviving patients 30 days post PCI (referred to
as baseline in the remainder of the paper) were approa-
ched by mail and asked to complete a set of psychological
questionnaires. The same set of questionnaires was
administered 12 months post PCI. If the questionnaire
was not returned within 3 weeks, a reminder was sent to
the patient together with a new questionnaire. All the
patients were recommended to take clopidogrel for
6 months. The study protocol was approved by the
medical ethics committee of the Erasmus Medical Center.
All patients provided written informed consent, and the
study was carried out in accordance with the Helsinki
Declaration.
Materials
Demographic and clinical variables
Demographic variables included gender and age. Infor-
mation on clinical variables (i.e., indication for PCI, multi-
vessel disease, previous myocardial infarction (MI), pre-
vious PCI, previous coronary artery bypass graft surgery
(CABG), hypertension, hypercholesterolemia, diabetes),
and cardiac medication (i.e., aspirin, calcium antagonists,
beta-blockers, ACE inhibitors, statins, diuretics) were
obtained from the patients’ medical records, except for
smoking, which was assessed by means of self-report.
Negative and positive affect
Negative and positive affect were assessed with the Global
Mood Scale [20]. The GMS comprises 10 negative affect
terms (e.g., ‘‘helpless’’ and ‘‘insecure’’), and 10 positive
affect terms (e.g., ‘‘active’’ and ‘‘cheerful’’) that are rated
on a 5-point Likert scale from 0 (not at all) to 4 (extre-
mely). Hence, scores on both the negative affect and
positive affect subscales range from 0 to 40. A median split
on the GMS scales was used to identify patients who
reported high (above median) versus low (median or
below) affect at baseline [21, 22]. For the negative affect
subscale, the median score was 10; for the positive affect
subscale, the median score was 22. The GMS was initially
validated in Belgian men with CAD and was found to be a
psychometrically sound measure in terms of construct
validity, internal consistency (Cronbach’s a[ .90), and
test–retest reliability (r [ .57) [20]. A number of studies by
independent authors have confirmed the psychometric
properties in cardiac patients [19, 23, 24] and recently also
in noncardiac adults from the working population [25]. In
the current study, the internal consistency, as measured by
Cronbach’s a, was high for both the negative (a = .91) and
positive affect subscales (a = .93). Moreover, the GMS
has been shown to be responsive to treatment-related
changes in negative and positive affect among cardiac
patients [21, 23].
Health status
The EuroQol-5D (EQ-5D), a well-known generic measure
of perceived health status developed by the EuroQol
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Group, was used as a measure of health status [26]. The
measure consists of two parts: the EQ visual analogue scale
(EQ VAS) and the EQ-5D descriptive system. On the EQ
VAS, the respondent is asked to mark his/her current health
state on a thermometer ranging from zero (worst imagin-
able health state) to 100 (best imaginable health state). This
information is used as a quantitative measure of the
respondent’s overall perceived health status. The EQ-5D
descriptive system comprises five questions tapping into
the respondent’s current health status in each of the fol-
lowing domains: Mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression. Each question can be
scored as: having no problems (level 1), some problems
(level 2), or severe problems (level 3). In the present study,
the EQ-5D levels were dichotomized into ‘no problems’
(i.e., level 1) versus ‘problems’ (i.e., levels 2 and 3) [27].
Dichotomization of patient-centered outcomes has been
advocated previously in order to enhance clinical inter-
pretability [28]. Based on the EQ-5D domains, it is also
possible to calculate a utility score, a single summary index
useful in cost utility analysis. However, in the current
study, we did not use this score as we did not compare two
treatment options and their associated costs. The EQ-5D is
a brief and practical instrument with satisfactory validity
and reliability for various diseases, including CAD, and for
the general population [29, 30].
Statistical analyses
Discrete variables were compared with the Chi-square test
and continuous variables with Student’s t-test for inde-
pendent samples. To examine the impact of baseline affect
on overall health status (EQ VAS) at 12-month follow-up,
analysis of variance (ANOVA) was used with dichoto-
mized negative and positive affect scores as between-sub-
ject factors. Analysis of covariance (ANCOVA) was
performed to adjust for the potential confounding effects of
baseline health status, age, gender, multi-vessel disease,
cardiac history (defined as previous MI, PCI, or CABG),
comorbidity (defined as hypertension, hypercholesterol-
emia, or diabetes), and smoking. To examine the impact of
baseline affect on the five health status domains (EQ-5D
descriptive system) at 12-month follow-up, univariable and
multivariable logistic regression analyses were used. In
multivariable analysis, we adjusted for the previously
mentioned covariates. All variables were entered simulta-
neously in the multivariable models. In secondary analyses,
the interaction effect, negative affect by positive affect was
also included, to examine whether positive affect moder-
ated the effect of negative affect on perceived health status.
All tests were two-tailed, and P \ .05 was used to
indicate statistical significance; in logistic regression
analysis, odds ratios (OR) and their corresponding 95%
confidence intervals (CI) are reported. All data were ana-
lyzed using SPSS.17.0 for Windows (SPSS Inc., Chicago,
Illinois).
Results
Participants versus nonparticipants on baseline
characteristics
Of 1,238 eligible patients treated with PCI in the study
period, 66 died within 30 days. The remaining 1,172
patients were asked to participate in the study, of which
870 (74.2%) agreed. Participants (n = 870) were more
likely to be older (mean 62.7 ± 11.5 vs. 60.2 ± 13.4;
P = .006) to have hypercholesterolemia (81.0% vs. 71.9%;
P = .001), and to be prescribed aspirin (92.6% vs. 87.1%;
P = .005) compared to nonparticipants (n = 302). No
other statistically significant differences were found
between participants and nonparticipants on baseline
characteristics. Of the 870 patients who agreed to partici-
pate, 67 did not fill in the GMS at follow-up. Of the
remaining 803 patients, only 562 patients completed the
entire EQ-5D descriptive system at follow-up and 533 the
EQ VAS. Unfortunately, imputation of missing data was
not an option because the EQ-5D descriptive system
comprises only one question per domain, as does the EQ
VAS. Hence, the main analyses focusing on the association
between negative and positive affect and the EQ VAS are
based on 533 patients, and the analysis related to the EQ-
5D descriptive system on 562 patients.
Baseline characteristics of the total sample
and stratified by affect
Baseline characteristics for the total sample and stratified
by negative and positive affect using a median split are
presented in Table 1. Patients who scored high (above the
median) on negative affect were more likely to be female
(36% vs. 20%; P \ .001), to have had a previous PCI (31%
vs. 20.3%; P = .004), hypercholesterolemia (86.8% vs.
78.8%; P = .014), diabetes (17.4% vs. 10.0%; P = .011),
to be smoking (28.9% vs. 20.0%; P = .014), and to be
prescribed diuretics (11.2% vs. 5.6%; P = .017) compared
to patients who scored low on negative affect. Patients who
scored high on positive affect were less likely to have
diabetes (10.2% vs. 16.6%; P = .03) compared to patients
who scored low on positive affect. No other statistically
significant differences were found on baseline demo-
graphics, clinical characteristics, and medication between
groups.
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Negative and positive affect as determinants
of self-reported health status
Overall health status (EQ VAS)
For the 533 patients that completed the EQ VAS, the mean
score at 12-month follow-up was 73.76 (±17.37). Uni-
variable ANOVA showed a main effect for negative affect
[F(1, 529) = 104.58, P \ .001] and for positive affect
[F(1, 529) = 19.93, P \ .001] and a significant interaction
for negative affect by positive affect [F(1, 529) = 7.87,
P = .005]. Adjusting for covariates, the main and inter-
action effects of affect remained significant in ANCOVA.
Patients with high negative affect reported significantly
poorer overall health status than patients with low negative
affect [F(1, 522) = 17.14, P \ .001]. Patients with high
positive affect reported significantly better overall health
status than patients with low positive affect [F(1,
522) = 5.11, P = .02]. The significant interaction for
negative affect by positive affect [F(1, 522) = 6.11,
P = .01] indicated that positive affect moderated the effect
of negative affect on overall health status (Fig. 1). Of the
Table 1 Baseline characteristics for the total sample (n = 562) and stratified by affect
Total
(n = 562)
GMS negative affect (cut-off C10) GMS positive affect (cut-off C22)
Low
(n = 320)
High
(n = 242)
P Low
(n = 259)
High
(n = 303)
P
Demographics
Female gender 151 (26.9) 64 (20.0) 87 (36.0) \.001*** 77 (29.7) 74 (24.4) .16
Age, mean (SD) 62.4 (10.8) 62.1 (10.0) 62.9 (11.8) .40 63.2 (11.0) 61.7 (10.5) .09
Clinical variables
MI as indication for PCI 191 (34.0) 110 (34.4) 81 (33.5) .82 83 (32.0) 108 (35.6) .37
Multi-vessel disease 261 (46.4) 155 (48.4) 106 (43.8) .27 117 (45.2) 144 (47.5) .58
Previous MI 143 (25.4) 75 (23.4) 68 (28.1) .21 63 (24.3) 80 (26.4) .57
Previous PCI 140 (24.9) 65 (20.3) 75 (31.0) .004** 69 (26.6) 71 (23.4) .38
Previous CABG 44 (7.8) 24 (7.5) 20 (8.3) .74 22 (8.5) 22 (7.3) .59
Hypertension 236 (42.0) 132 (41.2) 104 (43.0) .68 114 (44.0) 122 (40.3) .37
Hypercholesterolemia 462 (82.2) 252 (78.8) 210 (86.8) .014* 220 (84.9) 242 (79.9) .12
Diabetes 74 (13.2) 32 (10.0) 42 (17.4) .011* 43 (16.6) 31 (10.2) .03*
Smoking 134 (23.8) 64 (20.0) 70 (28.9) .014* 70 (27.0) 64 (21.1) .10
Medication
Aspirin 524 (93.2) 301 (94.1) 223 (92.1) .37 239 (92.3) 285 (94.1) .40
Calcium antagonists 17 (3.0) 7 (2.2) 10 (4.1) .18 9 (3.5) 8 (2.6) .57
Beta-blockers 359 (63.9) 206 (64.4) 153 (63.2) .78 165 (63.7) 194 (64.0) .94
ACE inhibitors 211 (37.5) 112 (35.0) 99 (40.9) .15 95 (36.7) 116 (38.3) .70
Statins 420 (74.7 245 (76.6) 175 (72.3) .25 192 (74.1) 228 (75.2) .76
Diuretics 45 (8.0) 18 (5.6) 27 (11.2) .017* 22 (8.5) 23 (7.6) .69
Results are presented as n (%), unless otherwise stated
MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft surgery
* P \ .05; ** P \ .01; *** P \ .001
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Fig. 1 Interaction of baseline negative affect with positive affect.
*** P \ .001. Means are adjusted for covariates (baseline EQ VAS,
age, gender, MVD, cardiac history, comorbidity, and smoking)
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covariates, there was a main effect for baseline EQ VAS
score [F(1, 522) = 163.22, P \ .001] and age [F(1,
522) = 5.28, P = .02].
Domain-specific health status (EQ-5D descriptive system)
Of the 562 patients that completed the EQ-5D descriptive
system, 178 (21.7%) patients reported mobility problems;
26 (4.6%) patients problems with self-care; 160 (28.5%)
patients problems in usual activities; 215 (38.3%) patients
pain/discomfort; and 130 (23.1%) patients symptoms of
anxiety/depression, 12 months post PCI.
In univariable logistic regression analysis, entering the
main effects for baseline negative affect and positive affect
simultaneously, high negative affect had the strongest
significant association with problems in all five domains:
Mobility (OR: 4.17; 95% CI: 2.79–6.24; P \ .001); self-
care (OR: 10.85; 95% CI: 2.47–47.59; P = .002); usual
activities (OR: 6.46; 95% CI: 4.15–10.05; P \ .001); pain/
discomfort (OR: 4.42; 95% CI: 3.00–6.51; P \ .001);
and anxiety/depression (OR: 4.34; 95% CI: 2.76–6.84;
P \ .001). Low positive affect had a weaker, but still
statistically significant association with problems with
self-care (OR: 5.12; 95% CI: 1.48–17.77; P = .01) and
usual activities (OR: 1.94; 95% CI: 1.26–2.98; P = .002);
the association with anxiety/depression problems was
borderline significant (OR: 1.54; 95% CI: .99–2.39;
P = .06), showing that a high score on positive affect was
protective of these problems. There was no significant
association between positive affect and the other two
dimensions, i.e., mobility and pain/discomfort.
Results of the multivariable analyses adjusted for
baseline EQ-5D score, gender, age, multi-vessel disease,
cardiac history, comorbidity, and smoking are shown in
Table 2. High negative affect remained an independent
associate of problems in all five domains, with ORs being
two to fivefold (i.e., OR: 2.43 for pain/discomfort and OR:
5.33 for self-care). Low positive affect remained an inde-
pendent associate of problems in self-care (OR: 8.14; 95%
CI: 1.85–35.9; P = .006) and in usual activities (OR: 1.87;
95% CI: 1.17–3.00; P = .009) in adjusted analysis. There
was no significant interaction for negative affect by posi-
tive affect for each of the five domains.
Discussion
Self-reported health status is an important outcome mea-
sure in patients with CAD, but little is known about its
determinants [2]. Until now, data are limited and incon-
clusive about the association of affect, particularly positive
affect, with health status in CAD patients. Results of the
current study demonstrated that baseline negative and T
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positive affect are independently associated with health
status 12 months post PCI, adjusting for demographic and
clinical factors and baseline health status.
After baseline health status, negative affect was the most
important independent associate of 12-month overall health
status in this study, followed by positive affect and age.
These results are in line with the findings of Dua [31], but
inconsistent with more recent findings in the healthy
elderly showing stronger associations between health status
and positive affect [15, 16]. An explanation for this
inconsistency could be the diversity of health status indices
used across studies [16], as research indicates that positive
and negative affect generally are related to different types
of health status. Watson [32] reported that negative affect
is strongly associated with perceived stress and health
complaints, while positive affect is highly related to social
activity and exercise. To investigate this, we additionally
analyzed the influence of both types of affect on specific
health status domains; that is physical functioning
(mobility and self-care), social functioning (usual activi-
ties), mental functioning (anxiety/depression), and pain/
discomfort [29]. The results showed that the incidence of
problems in each of the health status domains at 12-month
follow-up were significantly higher in patients reporting
high negative affect versus those reporting low negative
affect at baseline, with the associated risk being two to
fivefold adjusting for demographic and clinical factors, and
positive affect. A low baseline score on positive affect was
associated with problems in self-care and usual activities
only, with ORs of 8.14 and 1.87, respectively. These results
support the notion that positive and negative affects are not
merely the opposite ends of a continuum [14], and point to
the usefulness of including separate positive and negative
affect scales in health outcomes research.
In the current study, we were also able to replicate that
positive affect moderated the detrimental effect of negative
affect on overall health status in CAD patients [17, 18].
Patients reporting high negative and positive affect repor-
ted a much better overall health status compared to patients
reporting high negative affect and low positive affect. This
indicates that positive affect might play a protective role
for health status in the presence of negative affect. In line
with this finding, Fredrickson and Levenson [33] demon-
strated that positive emotions can dampen the physiologi-
cal reactivity evoked by negative emotions and interrupt or
shorten the damaging impact that this reactivity has on the
cardiovascular system.
Research on the specific mechanisms that link affect and
health outcomes is not yet clear [12]. Affect may influence
health directly by eliciting changes in neuroendocrine,
inflammatory, and immune processes [34–36]. Alterna-
tively, affect might influence people’s perceptions of and
decisions regarding their health [37]. Patients reporting
high negative affect may be more likely to notice and
attend to bodily sensations and to interpret them as painful
or pathological, while patients reporting high positive
affect may interpret ambiguous sensations in a more
positive way [35, 38]. In addition, affect can influence
health-promoting behaviors and adherence to treatment
[39, 40]. These potential pathways remain speculative as
they are yet to be tested empirically in future research.
More research is warranted to investigate the predictive
role of positive affect on hard medical endpoints in CAD,
including mortality. In contrast to the bulk of research
linking negative emotional states to clinical outcomes, a
paucity of studies have evaluated the impact of positive
psychological factors [41]. Up to now, only one study has
demonstrated that reduced positive affect was a significant
independent predictor of adverse clinical events following
PCI [11]. These and the present results indicate that CAD
patients might benefit from behavioral interventions, like
somatic relaxation training and mindfulness-based stress
reduction, focusing on enhancing positive affect, besides
reducing negative affect [42, 43].
The results of the current study should be interpreted
with some caution due to the following limitations. First,
since the study was observational, no firm conclusions can
be drawn regarding a cause-and-effect relationship
between affect and health status in CAD patients. How-
ever, it would be interesting to examine this in a clinical
trial manipulating affect. Second, we had no information
on left ventricular ejection fraction as this was not con-
sistently collected, but we did adjust for multi-vessel dis-
ease and previous cardiac history, as measures of disease
severity. Finally, we used a generic measure of health
status, which may be less clinically sensitive than a dis-
ease-specific measure [44].
Strengths of the study include its prospective design
with a follow-up period of 12 months and the relatively
large sample size. In addition, the majority of research on
the role of psychological factors in CAD has been con-
ducted in MI patients rather than in PCI patients and
focused on the studying of negative affect, such as
depression. Given the paucity and inconclusiveness of
research on affect and health status in CAD, the current
findings add to our understanding of the influence of
emotions on patient-centered health outcomes in cardiac
patients, indicating that negative affect and positive affect
should be studied in concert.
In conclusion, the present study showed that baseline
negative affect is a significant independent associate of
impaired 12-month health status in CAD patients, adjusting
for previously identified risk factors, including gender, age,
cardiac history, and comorbid conditions. Low positive
affect was associated with impaired health status above and
beyond negative affect and demographic and clinical risk
958 Qual Life Res (2009) 18:953–960
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factors, particularly for problems in self-care and usual
activities. These results indicate that positive affect might
play a protective role for health status and emphasize the
importance of studying positive affect in CAD in its own
right. Given these findings, cardiac rehabilitation should
not only target the reduction of negative emotions and
distress but also seek to enhance positive affect in indi-
vidual patients.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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